Results 91 to 100 of about 2,205,036 (277)

CLINICAL EFFICACY OF ALBUMIN DIALYSIS THERAPY FOR PATIENTS WITH HEPATORENAL SYNDROME

open access: yesВестник трансплантологии и искусственных органов, 2009
34 patients (23 male, 11 female) in the age of 41–77 years (mean age 59,7 ± 4,2 years) with 2 type hepatorenal syndrome were included in the study. All patients were divided in 3 groups.
D. E. Kutepov   +8 more
doaj   +1 more source

Meta‐Analysis: Effects of Steatotic Liver Disease‐Associated Genetic Risk Alleles on Longitudinal Outcomes

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
Genetic variants associated with risk of steatotic liver disease (SLD) may also influence clinical events. A systematic review and meta‐analysis consisting of 288,423 patients across 40 studies found that variants in PNPLA3, TM6SF2 and MBOAT7 are significantly associated with hepatic outcomes, with modest effects on extrahepatic outcomes.
Matthew Kubina   +15 more
wiley   +1 more source

Features of the course of hepatorenal syndrome in decompensated portal hypertension (case report)

open access: yesGastroenterologìa
Hepatorenal syndrome is a critical and potentially life-threatening complication in patients with advanced liver cirrhosis, characterized by the development of renal dysfunction in the absence of underlying structural kidney disease.
M.I. Tutchenko   +4 more
doaj   +1 more source

The impact of immature granulocytes on the outcome of patients with decompensated cirrhosis

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
Immature granulocyte (IG) count and percentage had a predictive role in patients with decompensated cirrhosis, making them an objective and easily available marker of prognosis for this group of patients. In addition, IG percentage was the only factor independently associated with transplant‐free survival.
Magdalini Adamantou   +10 more
wiley   +1 more source

A clinician’s guide to management of intra-abdominal hypertension and abdominal compartment syndrome in critically ill patients [PDF]

open access: yes, 2020
This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2020. Other selected articles can be found online at .
A Beurton   +49 more
core   +1 more source

Adaptation and Validation of the Supportive and Palliative Care Indicators Tool (SPICT): A Quantitative Methodological Study

open access: yesJournal of Advanced Nursing, EarlyView.
ABSTRACT Aims To translate the Supportive and Palliative Care Indicators Tool (SPICT) into Chinese and conduct preliminarily tests of its performance in hospitalized patients with cancer. Design A cross‐sectional validation study conducted from January to March 2024.
Yufei Huang   +4 more
wiley   +1 more source

Combined Liver-Kidney Transplantation for Hepatorenal Syndrome

open access: yesInternational Journal of Organ Transplantation Medicine, 2015
Among various complications of end-stage liver disease, hepatorenal syndrome has the highest mortality. Patients with both end-stage liver disease and end-stage renal disease are candidates for combined liver-kidney transplantation.
V Kanubhai Sutariya   +2 more
doaj  

Fucoidan alleviates the hepatorenal syndrome through inhibition organic solute transporter α/β to reduce bile acids reabsorption

open access: yesCurrent Research in Pharmacology and Drug Discovery, 2023
The high levels of bile acids are a critical factor in hepatorenal syndrome. Organic solute transporter α/β (Ostα/β) participate in bile acids reabsorption in the kidney.
Xiaojuan Zhao   +6 more
doaj  

Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal [PDF]

open access: yesClinical and Molecular Hepatology, 2014
Background/AimsA revised classification system for renal dysfunction in patients with cirrhosis was proposed by the Acute Dialysis Quality Initiative and the International Ascites Club Working Group in 2011.
Yun Jung Choi   +9 more
doaj   +1 more source

Acute liver disorders in the third trimester—AFLP, HELLP and infectious hepatitis—update on pathology, diagnosis and management

open access: yesThe Obstetrician &Gynaecologist, EarlyView.
Key content The epidemiology and pathophysiology of AFLP, HELLP syndrome and infectious viral hepatitis in late pregnancy. Clinical presentation, diagnosis and management of these conditions. Complications (maternal and fetal) and how these can be managed. The role of a multidisciplinary team in management.
Victor N. Chilaka   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy